Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

CHICAGO — Developments (and controversies) concerning drug-eluting stents (DES) — first and second-generation devices and those to come — weren't the only newsworthy topics at this year's scientific session of the American College of Cardiology (Washington).

From defects to heart monitoring, a panoply of device opportunities